Woodline Partners LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$374,588
-53.5%
150,437
-50.0%
0.00%
-63.6%
Q1 2023$806,342
-85.6%
300,874
-70.8%
0.01%
-85.3%
Q4 2022$5,587,291
+61.6%
1,028,967
+271.6%
0.08%
+56.2%
Q3 2022$3,458,000
-61.0%
276,900
-84.6%
0.05%
-65.0%
Q2 2022$8,878,0001,797,1820.14%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders